Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated safety, tolerability, and pharmacokinetics of tiotropium in cystic fibrosis patients. The update summarizes the tolerability and PK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED